Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial
2023 · Nature Medicine · 193 citations
https://doi.org/10.1038/s41591-022-02189-0
M
Mara B. Antonoff
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
595
Papers
8.7K
Citations
47
h-index
179
i10-index
Mara B. Antonoff is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Lung Cancer Diagnosis and Treatment & Lung Cancer Treatments and Mutations & Diversity and Career in Medicine. The author has an h-index of 47, co-authored 506 publications.
ORCID: 0000-0001-6247-9537Papers by this author
worksMulti-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma
2019 · Nature Communications · 181 citations
https://doi.org/10.1038/s41467-019-10877-8
American Academy of Pediatrics Section on Surgery hernia survey revisited
2005 · Journal of Pediatric Surgery · 129 citations
https://doi.org/10.1016/j.jpedsurg.2005.03.018
Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer
2023 · Nature Communications · 53 citations
https://doi.org/10.1038/s41467-023-36328-z
Intercostal Nerve Blocks With Liposomal Bupivacaine: Demonstration of Safety, and Potential Benefits
2017 · Seminars in Thoracic and Cardiovascular Surgery · 37 citations
https://doi.org/10.1053/j.semtcvs.2017.06.004
Extrapleural Pneumonectomy Versus Pleurectomy/Decortication for Malignant Pleural Mesothelioma
2021 · The Annals of Thoracic Surgery · 33 citations
https://doi.org/10.1016/j.athoracsur.2021.04.078
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat